Stock 2796 PHARMARISE HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharmarise Holdings Corporation

Equities

2796

JP3802320006

Drug Retailers

Market Closed - Japan Exchange
Other stock markets
 07:00:00 26/04/2024 BST 		5-day change 1st Jan Change
639 JPY -2.59% Intraday chart for Pharmarise Holdings Corporation -1.54% -3.18%
04-11 Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A MT
04-10 Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024 CI

Valuation

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Capitalization 1 6,156 4,740 6,164 7,211 6,809 5,759
Enterprise Value (EV) 1 13,053 11,475 12,921 13,304 12,730 10,155
P/E ratio -220 x 229 x 14.3 x 22.4 x 20.1 x 22.7 x
Yield 2.06% 2.73% 2.11% 1.81% 1.92% 2.29%
Capitalization / Revenue 0.11 x 0.09 x 0.12 x 0.14 x 0.13 x 0.11 x
EV / Revenue 0.24 x 0.22 x 0.25 x 0.25 x 0.25 x 0.2 x
EV / EBITDA 5.21 x 6.16 x 5.71 x 5.13 x 4.5 x 3.81 x
EV / FCF 11.5 x 18.4 x 12.7 x 9.37 x 57.6 x 5.14 x
FCF Yield 8.67% 5.43% 7.9% 10.7% 1.74% 19.4%
Price to Book 1.13 x 0.87 x 1.04 x 1.16 x 1.03 x 0.84 x
Nbr of stocks (in thousands) 9,039 9,240 9,298 9,305 9,353 9,426
Reference price 2 681.0 513.0 663.0 775.0 728.0 611.0
Announcement Date 29/08/18 29/08/19 27/08/20 27/08/21 26/08/22 31/08/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net sales 1 54,562 51,728 51,030 52,324 51,608 52,030
EBITDA 1 2,507 1,863 2,264 2,591 2,829 2,663
EBIT 1 1,181 640 1,036 1,247 1,521 1,439
Operating Margin 2.16% 1.24% 2.03% 2.38% 2.95% 2.77%
Earnings before Tax (EBT) 1 415 400 818 1,202 1,321 1,049
Net income 1 -28 23 577 426 447 333
Net margin -0.05% 0.04% 1.13% 0.81% 0.87% 0.64%
EPS 2 -3.098 2.240 46.32 34.59 36.22 26.86
Free Cash Flow 1 1,132 622.8 1,020 1,420 221 1,975
FCF margin 2.07% 1.2% 2% 2.71% 0.43% 3.8%
FCF Conversion (EBITDA) 45.15% 33.43% 45.06% 54.79% 7.81% 74.16%
FCF Conversion (Net income) - 2,707.61% 176.82% 333.22% 49.44% 593.09%
Dividend per Share 2 14.00 14.00 14.00 14.00 14.00 14.00
Announcement Date 29/08/18 29/08/19 27/08/20 27/08/21 26/08/22 31/08/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Mei 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 - 25,666 25,903 12,676 12,861 25,745 12,985 13,471 26,948 13,726
EBITDA - - - - - - - - - -
EBIT 1 - 525 788 212 348 573 323 331 710 153
Operating Margin - 2.05% 3.04% 1.67% 2.71% 2.23% 2.49% 2.46% 2.63% 1.11%
Earnings before Tax (EBT) 1 - 471 775 192 318 394 328 312 662 99
Net income 1 - 127 250 72 111 72 136 123 273 -96
Net margin - 0.49% 0.97% 0.57% 0.86% 0.28% 1.05% 0.91% 1.01% -0.7%
EPS 2 - 13.73 26.94 7.660 11.88 7.760 14.48 13.11 28.29 -11.07
Dividend per Share - - - - - - - - - -
Announcement Date - 14/01/21 13/01/22 12/04/22 13/10/22 29/12/22 30/03/23 02/10/23 25/12/23 25/03/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: Mei 2018 2019 2020 2021 2022 2023
Net Debt 1 6,897 6,735 6,757 6,093 5,921 4,396
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.751 x 3.615 x 2.985 x 2.352 x 2.093 x 1.651 x
Free Cash Flow 1 1,132 623 1,020 1,420 221 1,975
ROE (net income / shareholders' equity) -3.59% -0.18% 10% 6.84% 7.02% 5.07%
ROA (Net income/ Total Assets) 3.02% 1.65% 2.62% 3.12% 3.92% 3.81%
Assets 1 -925.7 1,394 22,021 13,646 11,396 8,732
Book Value Per Share 2 601.0 591.0 636.0 669.0 706.0 730.0
Cash Flow per Share 2 404.0 477.0 481.0 495.0 427.0 503.0
Capex 1 403 400 349 508 379 380
Capex / Sales 0.74% 0.77% 0.68% 0.97% 0.73% 0.73%
Announcement Date 29/08/18 29/08/19 27/08/20 27/08/21 26/08/22 31/08/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

1st Jan change Capi.
PHARMARISE HOLDINGS CORPORATION Stock Pharmarise Holdings Corporation
-3.18% 45.64M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-12.86% 8.57B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+32.95% 1.32B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
+6.76% 419M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+5.93% 282M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+10.56% 224M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-8.26% 85.07M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+20.94% 59.57M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. 2796 Stock
  4. Financials Pharmarise Holdings Corporation